Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

SYNAGEVA BIOPHARMA CORP (GEVA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07
   10-K10-K10-K10-K/A10-K10-K/A10-K10-K
Revenues   [+]6.513.415.02.10.6161.811.415.7
            Revenue growth  -51.5%-10.6%612.4%252.8%-99.6%1325.3%-27.8%33.1%
Cost of goods sold  -200.7-110.9-59.0-27.8-14.23,843.2-7.8-32.2
Gross profit  207.2124.373.929.914.8-3,681.419.247.9
            Gross margin  3191.9%929.0%494.4%1425.3%2489.6%-2274.8%169.0%304.5%
Selling, general and administrative   [+]54.527.617.49.33.93,843.27.711.1
Research and development  142.679.637.317.39.9 4.211.4
Other operating expenses  202.2113.062.228.314.22,739.8-0.50.0
EBITDA   [+]-186.1-90.3-38.7-24.0-12.7-9,924.68.325.8
            EBITDA margin  -2866.0%-675.5%-259.1%-1142.7%-2141.0%-6132.7%72.9%163.9%
Depreciation and amortization  4.63.51.00.50.4339.80.20.2
EBITA  -190.6-93.8-39.8-24.5-13.1-10,264.48.025.6
            EBITA margin  -2936.6%-701.6%-266.1%-1167.9%-2205.5%-6342.7%70.7%162.7%
Amortization of intangibles  1.52.13.20.5  0.20.2
EBIT   [+]-192.1-95.9-43.0-25.0-13.1-10,264.47.825.4
            EBIT margin  -2959.5%-717.1%-287.7%-1191.9%-2205.5%-6342.7%68.5%161.5%
Non-recurring items   [+]      0.50.0
Interest expense, net   [+]-0.3-0.3-0.10.00.01,238.2-1.7-2.4
Other income (expense), net   [+]-0.20.2 -0.32.382.5-1.3 
Pre-tax income  -192.1-95.4-42.9-25.3-10.8-11,420.17.727.8
Income taxes  0.50.00.00.00.00.0-0.30.4
            Tax rate    0.0%0.0%0.0%0.0% 1.4%
Net income  -192.6-95.5-42.9-25.3-10.8-11,420.18.027.4
            Net margin  -2967.5%-713.7%-287.2%-1205.6%-1819.2%-7056.8%70.5%174.4%
   
Basic EPS   [+]($5.89)($3.40)($1.90)($8.58)($338.25)($516.14)$0.36$1.24
Diluted EPS   [+]($5.89)($3.40)($1.90)($8.58)($338.25)($516.14)$0.36$1.24
   
   
Shares outstanding (basic)   [+]32.728.122.63.00.022.122.222.1
Shares outstanding (diluted)   [+]32.728.122.63.00.022.122.222.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy